News
Stockhead on MSN26m
Imagion shares rally after positive FDA feedback on path to phase II breast cancer trialImagion Biosystems receives positive feedback from US FDA for HER2 breast cancer phase II clinical trial. ... Read More The ...
She credited the same risk assessment test that led to her own diagnosis in 2023 with potentially saving her mother's life.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback